These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14671086)

  • 41. Use of synthetic peptides to identify measles nucleoprotein T-cell epitopes in vaccinated and naturally infected humans.
    Hickman CJ; Khan AS; Rota PA; Bellini WJ
    Virology; 1997 Sep; 235(2):386-97. PubMed ID: 9281519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of naturally processed peptides eluted from HLA DRB1*0402 and *0404.
    Hayden JB; McCormack AL; Yates JR; Davey MP
    J Neurosci Res; 1996 Sep; 45(6):795-802. PubMed ID: 8892091
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination.
    Ovsyannikova IG; Jacobson RM; Ryan JE; Dhiman N; Vierkant RA; Poland GA
    Clin Vaccine Immunol; 2007 Feb; 14(2):115-22. PubMed ID: 17215337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human B cells secrete migration inhibition factor (MIF) and present a naturally processed MIF peptide on HLA-DRB1*0405 by a FXXL motif.
    Wymann D; Blüggel M; Kalbacher H; Blesken T; Akdis CA; Meyer HE; Blaser K
    Immunology; 1999 Jan; 96(1):1-9. PubMed ID: 10233671
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of T cell epitopes in measles virus nucleoprotein.
    Marttila J; Ilonen J; Norrby E; Salmi A
    J Gen Virol; 1999 Jul; 80 ( Pt 7)():1609-1615. PubMed ID: 10423128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human leukocyte antigen class I- and class II-restricted cytotoxic T lymphocyte responses to measles antigens in immune adults.
    Jaye A; Magnusen AF; Whittle HC
    J Infect Dis; 1998 May; 177(5):1282-9. PubMed ID: 9593013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.
    Sakurai Y; Brand DD; Tang B; Rosloniec EF; Stuart JM; Kang AH; Myers LK
    Arthritis Res Ther; 2006; 8(5):R150. PubMed ID: 16982003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of HLA-DRB1*09:01-restricted Mycobacterium tuberculosis CD4
    Liu SD; Zhang SM; Wang H; He JC; Yang XF; Du XL; Ma L
    FEBS Lett; 2016 Dec; 590(24):4541-4549. PubMed ID: 27861807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101.
    Oswald-Richter K; Sato H; Hajizadeh R; Shepherd BE; Sidney J; Sette A; Newman LS; Drake WP
    J Clin Immunol; 2010 Jan; 30(1):157-66. PubMed ID: 19536643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.
    Dzuris JL; Sidney J; Horton H; Correa R; Carter D; Chesnut RW; Watkins DI; Sette A
    J Virol; 2001 Nov; 75(22):10958-68. PubMed ID: 11602736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.
    Endl J; Otto H; Jung G; Dreisbusch B; Donie F; Stahl P; Elbracht R; Schmitz G; Meinl E; Hummel M; Ziegler AG; Wank R; Schendel DJ
    J Clin Invest; 1997 May; 99(10):2405-15. PubMed ID: 9153283
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Simple Proteomics-Based Approach to Identification of Immunodominant Antigens from a Complex Pathogen: Application to the CD4 T Cell Response against Human Herpesvirus 6B.
    Becerra-Artiles A; Dominguez-Amorocho O; Stern LJ; Calvo-Calle JM
    PLoS One; 2015; 10(11):e0142871. PubMed ID: 26599878
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide.
    Partidos CD; Vohra P; Steward MW
    Virology; 1996 Jan; 215(1):107-10. PubMed ID: 8553582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A predictive method for the evaluation of peptide binding in pocket 1 of HLA-DRB1 via global minimization of energy interactions.
    Androulakis IP; Nayak NN; Ierapetritou MG; Monos DS; Floudas CA
    Proteins; 1997 Sep; 29(1):87-102. PubMed ID: 9294869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Counter-antigen presentation: fibroblasts produce cytokines by signalling through HLA class II molecules without inducing T-cell proliferation.
    Ohyama H; Nishimura F; Meguro M; Takashiba S; Murayama Y; Matsushita S
    Cytokine; 2002 Feb; 17(4):175-81. PubMed ID: 11991669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of Th0 cells responding to measles virus.
    Howe RC; Ovsyannikova IG; Pinsky NA; Poland GA
    Hum Immunol; 2005 Feb; 66(2):104-15. PubMed ID: 15694995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vigorous but short-term gamma interferon T-cell responses against a dominant HLA-A*02-restricted measles virus epitope in patients with measles.
    Jaye A; Herberts CA; Jallow S; Atabani S; Klein MR; Hoogerhout P; Kidd M; van Els CA; Whittle HC
    J Virol; 2003 Apr; 77(8):5014-6. PubMed ID: 12663809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of an artificial-antigen-presenting-cell-based assay for the detection of low-frequency virus-specific CD8(+) T cells in whole blood, with application for measles virus.
    Ndhlovu ZM; Angenendt M; Heckel D; Schneck JP; Griffin DE; Oelke M
    Clin Vaccine Immunol; 2009 Jul; 16(7):1066-73. PubMed ID: 19494085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Three novel NY-ESO-1 epitopes bound to DRB1*0803, DQB1*0401 and DRB1*0901 recognized by CD4 T cells from CHP-NY-ESO-1-vaccinated patients.
    Mizote Y; Taniguchi T; Tanaka K; Isobe M; Wada H; Saika T; Kita S; Koide Y; Uenaka A; Nakayama E
    Vaccine; 2010 Jul; 28(32):5338-46. PubMed ID: 20665979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peptide HER2(776-788) represents a naturally processed broad MHC class II-restricted T cell epitope.
    Sotiriadou R; Perez SA; Gritzapis AD; Sotiropoulou PA; Echner H; Heinzel S; Mamalaki A; Pawelec G; Voelter W; Baxevanis CN; Papamichail M
    Br J Cancer; 2001 Nov; 85(10):1527-34. PubMed ID: 11720440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.